Is there any reason to withhold α2 agonists from patients with coronary disease during surgery? [6] (multiple letters)

Luc Quintin, Marco Ghignone, Michael Zaugg, Marcus C. Schaub, Martin J. London, Donat R. Spahn, Miklos D. Kertai, Jeroen J. Bax, Jan Klein, Don Poldermans

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1244-1246
Number of pages3
JournalAnesthesiology
Volume101
Issue number5
DOIs
Publication statusPublished - Nov 1 2004

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Quintin, L., Ghignone, M., Zaugg, M., Schaub, M. C., London, M. J., Spahn, D. R., Kertai, M. D., Bax, J. J., Klein, J., & Poldermans, D. (2004). Is there any reason to withhold α2 agonists from patients with coronary disease during surgery? [6] (multiple letters). Anesthesiology, 101(5), 1244-1246. https://doi.org/10.1097/00000542-200411000-00036